Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNA interference (RNAi)
Biotech
City lays foundation for RNAi renaissance with nearly $100M
In addition to a lead liver-directed candidate targeting clotting protein Factor XI, City aims to expand the reach of RNAi to the rest of the body.
Darren Incorvaia
Jun 8, 2026 4:00pm
Roche continues RNA return with $1.7B deal for Sanegene drug
Feb 2, 2026 8:35am
Irish biotech launches with $21M to shuttle RNAi meds to brain
Oct 1, 2025 10:34am
Corsera launches with $50M for predictive AI tool, RNAi asset
Sep 2, 2025 6:30am
Federal mRNA vax grant cuts includes unrelated project
Aug 7, 2025 2:20pm
Sanofi pens $395M China pact for Arrowhead metabolic med
Aug 1, 2025 7:21am
